How Mapping COVID-19 Could Help Drug Companies
Excerpt from the article:
When the spread of COVID-19 started to affect the University of Connecticut, the state, and the country, Ranjan Srivastava, department head for Chemical and Biomolecular Engineering, knew he had to spring into action.
Drawing on his previous work in mathematically modeling how the Hepatitis B virus spreads, Srivastava realized he could apply the principles of what he knew to the behavior of COVID-19, which could be useful to other researchers and drug companies.
Click the button below to read the entire article:
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?